浏览全部资源
扫码关注微信
1.南京中医药大学附属医院(江苏 南京 210029)
2.南京中医药大学(江苏 南京 210023)
陈易珠,女,硕士研究生,主要从事中医药防治心血管疾病临床研究工作
刘福明,主任医师,博士研究生导师; E-mail:doctor.liufuming@outlook.com
纸质出版日期:2024-07-10,
收稿日期:2023-05-20,
扫 描 看 全 文
陈易珠,李彩霞,刘梦君,等.中医药益气温阳、活血利水法治疗慢性心力衰竭作用机制的研究进展[J].上海中医药杂志,2024,58(7):89-94.
CHEN Yizhu,LI Caixia,LIU Mengjun,et al.Research progress on mechanism of nourishing qi and warming yang, activating blood and diverting water of traditional Chinese medicine in treatment of chronic heart failure[J].Shanghai Journal of Traditional Chinese Medicine,2024,58(7):89-94.
陈易珠,李彩霞,刘梦君,等.中医药益气温阳、活血利水法治疗慢性心力衰竭作用机制的研究进展[J].上海中医药杂志,2024,58(7):89-94. DOI: 10.16305/j.1007-1334.2024.2305058.
CHEN Yizhu,LI Caixia,LIU Mengjun,et al.Research progress on mechanism of nourishing qi and warming yang, activating blood and diverting water of traditional Chinese medicine in treatment of chronic heart failure[J].Shanghai Journal of Traditional Chinese Medicine,2024,58(7):89-94. DOI: 10.16305/j.1007-1334.2024.2305058.
综述中医药益气温阳、活血利水法治疗慢性心力衰竭作用机制的研究进展。慢性心力衰竭可依据阳气虚弱、心血瘀阻、水饮内停的病机,采用中医药益气温阳、活血利水法治疗。研究显示,该法治疗慢性心力衰竭的临床疗效显著,其机制主要与改善心肌纤维化及心室重构、调节氧化应激反应、改善血流动力学障碍与心肌能量代谢、干预相关信号通路、缓解利尿剂抵抗等有关。
This article reviews the research progress on the mechanism of the traditional Chinese medicine therapy of chronic heart failure by using treatment of nourishing qi and warming yang, activating blood and diverting water, which based on the traditional Chinese pathogenesis of yang qi weakness, heart blood stasis, water stopping. And the research shows that the clinical efficacy of this method in the treatment of chronic heart failure is significant, and the mechanism is mainly related to improving myocardial fibrosis and ventricular remodeling, regulating the oxidative stress response, improving hemodynamic disorders and myocardial energy metabolism, intervening related signaling pathways, and relieving diuretic resistance.
慢性心力衰竭益气温阳活血利水作用机制中医药疗法研究进展
chronic heart failurenourishing qi and warming yangactivating blood and diverting watermechanism of actiontraditional Chinese medicine therapyresearch progress
MCDONAGH T A, METRA M, ADAMO M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Eur Heart J, 2021, 42(36): 3599-3726.
HAO G, WANG X, CHEN Z, et al. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012-2015[J]. Eur J Heart Fail, 2019, 21 (11) :1329-1337.
SAVARESE G, BECHER P M, LUND L H, et al. Global burden of heart failure: a comprehensive and updated review of epidemiology[J]. Cardiovasc Res, 2023, 118(17): 3272-3287.
解聪慧,乔文彪,胡勇,等. 《黄帝内经》的心力衰竭理论研究[J]. 中华中医药杂志, 2022, 37(11): 6429-6432.
左梦雨,汤同娟,王翔,等. 基于数据挖掘的张仲景治疗心系疾病用药规律分析[J]. 安徽医药, 2022, 26(6): 1254-1258.
李硕思,杨艳卓. 近现代中医名家对心病虚证的治验总结[J]. 亚太传统医药, 2023, 19(7): 176-181.
王恒坤,张芸旗,张杰. 张杰教授运用经方辨治心脏疾病经验[J]. 浙江中医药大学学报, 2021, 45(11): 1178-1183.
陈佳斌,秦佳枫,赵钢. 慢性心力衰竭的中西医发病机制及其治疗进展[J]. 中西医结合心脑血管病杂志, 2019, 17(3): 378-380.
王华,刘宇佳,杨杰孚. 心力衰竭流行病学[J]. 临床心血管病杂志,2023, 39(4): 243-247.
HEIDENREICH P A, BOZKURT B, AGUILAR D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines[J]. Circulation, 2022,145(18): e895-e1032.
GUIDETTI F, ARRIGO M, FRANK M, et al. Treatment of advanced heart failure-focus on transplantation and durable mechanical circulatory support: What does the future hold?[J]. Heart Fail Clin, 2021, 17(4): 697-708.
GONZÁLEZ A, RICHARDS A M, DE BOER R A, et al. Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology[J]. Eur J Heart Fail, 2022, 24(6): 927-943.
ACCORNERO F, VAN BERLO J H, CORRELL R N, et al. Genetic analysis of connective tissue growth factor as an effector of transforming growth factor β signaling and cardiac remodeling[J]. Mol Cell Biol, 2015, 35 (12) : 2154-2164.
ZHOU Y, ZHU Y, ZENG J. Research update on the pathophysiological mechanisms of heart failure with preserved ejection fraction[J]. Curr Mol Med, 2022, 23 (1): 54-62.
BUFFOLO F, TETTI M, MULATERO P, et al. Aldosterone as a mediator of cardiovascular damage[J]. Hypertension, 2022, 79(9): 1899-1911.
郭宁,张胜高. 芪附强心汤治疗心阳虚血瘀型冠心病慢性心力衰竭临床研究[J]. 中西医结合研究, 2022, 14(2): 77-80, 88.
王艳丽,王艳萍,马金波,等. 芪苈强心胶囊辅治扩张型心肌病合并慢性心力衰竭的疗效及对神经内分泌因子、炎性因子及心室重构的影响[J]. 解放军医药杂志, 2021, 33(2): 84-88.
周亚,赵春生,张煦,等. 基于“正气存内,邪不可干”论治心力衰竭的免疫损伤[J]. 中医药临床杂志, 2022, 34(11): 2024-2028.
金蕾,潘东辉. 温阳益心汤对慢性心力衰竭(阳气虚衰、血瘀水停型)心功能和炎症因子的影响[J]. 光明中医, 2021, 36(5): 760-763.
朱艳,严夏. 苓桂术甘汤加味方对慢性心力衰竭患者血清TNF-α、IL-10及TGF-β1水平的影响[J]. 广州中医药大学学报, 2019, 36(12): 1886-1890.
冯庆涛,杨静,张燕,等. 参桂益心汤对慢性心力衰竭患者外周血单核细胞Toll样受体4/核转录因子-κB信号通路的影响[J]. 中国实验方剂学杂志, 2017, 23(23): 146-151.
郭依宁,刘景,王俊岩,等. 心阳片含药血清调控NLRP3介导细胞焦亡保护心肌细胞炎症损伤的作用及机制研究[J]. 中华中医药学刊, 2021, 39(8): 92-96, 271.
陈余文,王悦,李冰清,等. 钠-葡萄糖共转运蛋白2抑制剂抗氧化应激机制的研究进展[J]. 实用心脑肺血管病杂志, 2022, 30(10): 125-128.
MARTINS D, GARCIA L R, QUEIROZ D A R, et al. Oxidative stress as a therapeutic target of cardiac remodeling[J]. Antioxidants (Basel), 2022 , 11(12): 2371.
谢健燕. 生脉真武救心汤对心力衰竭患者氧化应激状态影响的研究[J]. 新中医, 2019, 51(5): 119-122.
李彬,王新陆,谢世阳,等. 参附益心方对缺氧原代心肌细胞活性氧和能量代谢的影响[J]. 中国药房, 2019, 30(8): 1018-1024.
TEUBER J P, ESSANDOH K, HUMMEL S L, et al. NADPH oxidases in diastolic dysfunction and heart failure with preserved ejection fraction[J]. Antioxidants (Basel), 2022, 11(9):1822.
YUYUN M F, NG L L, NG G A. Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5‑methyltetrahydrofolate in cardiovascular disease. Where are we with therapy?[J]. Microvasc Res, 2018, 119: 7-12.
姜冬云,吴亚梅. 茯苓四逆汤化裁方对心肾阳虚型慢性心力衰竭大鼠肾素-血管紧张素-醛固酮系统(RAAS)及血液流变学的影响[J]. 四川中医, 2022, 40(11): 58-63.
李超,范辉,王晓峰.芪红散辅助治疗慢性心力衰竭的疗效及对左心收缩功能、血流动力学状态的影响[J]. 环球中医药, 2018, 11(4): 590-592.
ZHOU B, TIAN R. Mitochondrial dysfunction in pathophysiology of heart failure[J]. J Clin Invest, 2018, 128 (9) :3716-3726.
FUKUSHIMA A, MILNER K, GUPTA A, et al.Myocardial energy substrate metabolism in heart failure: from pathways to therapeutic targets[J]. Curr Pharm Des, 2015, 21 (25) : 3654-3664.
BERTERO E, MAACK C. Reply to metabolic remodelling in heart failure revisited[J]. Nat Rev Cardiol, 2018, 15(12): 780-781.
李佳卓,张鸿婷,邹国良,等. 燧心胶囊治疗慢性心力衰竭临床疗效及对患者心肌能量代谢、心脏功能的影响[J]. 世界中西医结合杂志, 2022, 17(4): 806-810.
刘倩茹,王新陆,朱明军,等. 参附益心颗粒对AngⅡ诱导的H9c2心肌细胞损伤及PGC-1α信号通路相关因子的影响[J]. 中医杂志,2022, 63(7): 679-687.
谢世阳,王幼平,崔琳,等. 参附益心颗粒对心肌梗死后心力衰竭大鼠心肌线粒体呼吸功能的影响[J]. 中国中西医结合杂志, 2020, 40(1): 59-64.
靳利利,袁丁,史振羽,等. 加味参附颗粒对慢性心力衰竭大鼠心肌超微结构的影响[J]. 中国中医急症, 2014, 23(4): 602-604.
郭迪. 强心活力方对慢性心力衰竭大鼠作用及机制研究[D]. 长春:长春中医药大学, 2018.
陈婵,娄洋,吕铮天,等. 益心化浊方对慢性心力衰竭大鼠肠道TLR4/Treg信号通路的影响[J].中国中西医结合杂志, 2021, 41(10): 1214-1220.
WANG S, BINDER P, FANG Q, et al. Endoplasmic reticulum stress in the heart: insights into mechanisms and drug targets[J]. Br J Pharmacol, 2018, 175 (8) : 1293-1304.
康锦花,宁怡乐,龙文杰,等. 基于RyR2调控Ca2+信号探讨心阳片防治慢性心力衰竭的机制[J]. 中华中医药杂志, 2022, 37(11): 6832-6836.
GUPTA R, TESTANI J, COLLINS S. Diuretic resistance in heart failure[J]. Curr Heart Fail Rep, 2019 , 16(2): 57-66.
马妍,任得志,邱克伟,等. 慢性心力衰竭利尿剂抵抗的发病机制与治疗进展[J]. 世界中医药, 2022, 17(4): 590-594.
陈晨,宋红莉,陈会娟,等. 茯苓杏仁甘草汤加味联合中药熏洗对心衰伴利尿剂抵抗(气虚血瘀水阻型)患者心功能的影响[J]. 吉林中医药, 2023, 43(4): 423-427.
杨伟,郝小康,杨永彦,等. 温阳利水活血方佐治老年慢性心力衰竭伴利尿剂抵抗的疗效[J]. 西藏医药, 2022, 43(6): 134-136.
祁姚鑫瑞,郇鹏飞,范家翎,等. 附仙强心方对慢性心力衰竭阳虚水泛证大鼠sST2、CaN的影响[J]. 上海中医药杂志, 2023, 57(7): 51-57.
0
浏览量
0
下载量
0
CSCD
0
CNKI被引量
关联资源
相关文章
相关作者
相关机构